Published in Liver Transpl on October 01, 2014
Transarterial chemoembolization and radiological vascular complications. Liver Transpl (2015) 1.06
Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82
Reply: To PMID 25045002. Liver Transpl (2015) 0.75
Common ultrasound and contrast-enhanced ultrasonography in the diagnosis of hepatic artery pseudoaneurysm after liver transplantation. Exp Ther Med (2016) 0.75
Transarterial chemoembolization does not harm the hepatic artery at transplantation. Liver Transpl (2015) 0.75
Early Hepatic Artery Thrombosis After Liver Transplantation: What is the Impact of the Arterial Reconstruction Type? World J Surg (2017) 0.75
Management of hepatocellular carcinoma: an update. Hepatology (2011) 33.57
Management of hepatocellular carcinoma. Hepatology (2005) 27.42
Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis (1999) 12.31
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology (2009) 5.87
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology (2010) 5.44
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg (1992) 2.76
Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl (2006) 2.62
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl (2011) 2.10
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl (2003) 2.04
Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment. World J Surg (2007) 1.73
Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations. Hepatology (2012) 1.37
Complications of hepatic chemoembolization. Semin Intervent Radiol (2006) 1.35
Development of organ-specific donor risk indices. Liver Transpl (2012) 1.26
Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol (2008) 1.18
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl (2012) 1.18
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol (1998) 1.17
Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States. J Hepatol (2011) 1.08
Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Crit Rev Oncol Hematol (2010) 1.05
Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med (2008) 1.03
Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. J Vasc Interv Radiol (2013) 0.99
Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma. Radiology (2000) 0.97
Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft. Clin Transplant (2005) 0.96
Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Cardiovasc Intervent Radiol (2007) 0.85
Hepatic artery anastomotic stenosis after transplantation: treatment with percutaneous transluminal angioplasty. Radiology (1989) 0.84
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet (2010) 4.47
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl (2014) 3.11
Metal-organic framework materials as catalysts. Chem Soc Rev (2009) 2.96
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology (2003) 2.64
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol (2010) 2.51
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl (2013) 2.48
Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology (2003) 2.38
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology (2006) 2.26
Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol (2012) 2.22
Liver allocation and distribution: possible next steps. Liver Transpl (2011) 2.14
Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol (2013) 2.11
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transpl (2007) 2.08
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Physician - nurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients' perception of care. J Interprof Care (2003) 1.93
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.89
Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg? Hepatology (2015) 1.87
Hospital accused of experiments on pregnant women. BMJ (1994) 1.73
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer (2011) 1.70
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res (2008) 1.68
Hepatitis C virus and lichen planus: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 1.62
US researchers fail to get informed consent. BMJ (1994) 1.61
Are HIV-infected patients candidates for liver transplantation? J Hepatol (2008) 1.59
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med (2003) 1.58
Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Cancer Res (2009) 1.58
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver Transpl (2006) 1.56
The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol (2008) 1.55
Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51
Prevalence of HBV precore/core promoter variants in the United States. Hepatology (2003) 1.47
The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I. Eur J Nucl Med Mol Imaging (2002) 1.45
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transpl (2002) 1.45
One size does not fit all: using qualitative methods to inform the development of an Internet portal for multiple sclerosis patients. AMIA Annu Symp Proc (2005) 1.42
Organ donation after cardiac death in amyotrophic lateral sclerosis. Ann Neurol (2012) 1.41
Privacy protection for your patients: understanding the federal requirements. Cleve Clin J Med (2003) 1.39
Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci (2010) 1.30
Hepatocellular carcinoma: Ablate and wait versus rapid transplantation. Liver Transpl (2010) 1.26
Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS (2009) 1.25
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. Br J Clin Pharmacol (2013) 1.24
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transpl (2012) 1.18
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13
Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy. J Hepatol (2008) 1.11
Reducing the rate of repeat imaging: import of outside images to PACS. AJR Am J Roentgenol (2012) 1.10
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl (2011) 1.08
Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys (2006) 1.05
Development of a murine model of chronic rhinosinusitis. Otolaryngol Head Neck Surg (2006) 1.02
Primary repair of ulnar collateral ligament injuries of the elbow in young athletes: a case series of injuries to the proximal and distal ends of the ligament. Am J Sports Med (2008) 1.00
Viral hepatitis and inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.00
De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99
Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology (2006) 0.99
Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies. Curr Opin Organ Transplant (2012) 0.99
Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. Am J Cardiol (2008) 0.98
Multidisciplinary management of hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 0.98
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl (2011) 0.97
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology (2004) 0.96
Association of Menstrual-Cycle Hormone Changes with Anterior Cruciate Ligament Laxity Measurements. J Athl Train (2003) 0.95
Experimental renal artery embolization in a combined MR imaging/angiographic unit. J Vasc Interv Radiol (2003) 0.93
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology (2002) 0.92
Complications associated with the percutaneous insertion of fiducial markers in the thorax. Cardiovasc Intervent Radiol (2010) 0.91
Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol (2005) 0.91
Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol (2013) 0.89
Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl (2010) 0.89
Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? Cancer (2005) 0.88
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors. Cancer Chemother Pharmacol (2009) 0.87
Primary bladder amyloidosis. Intern Med (2014) 0.87
Actinobacillus actinomycetemcomitans endogenous endophthalmitis: report of two cases and review of the literature. Scand J Infect Dis (2003) 0.87
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl (2012) 0.86
Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era? Am J Gastroenterol (2013) 0.86
Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes. Transplantation (2014) 0.85
Management of recurrent airway strictures in lung transplant recipients using AERO covered stents. J Vasc Interv Radiol (2010) 0.85
The current status of pesticide resistance in Australian populations of the redlegged earth mite (Halotydeus destructor). Pest Manag Sci (2012) 0.85
Preconsultation exchange for ambulatory hepatology consultations. Am J Med (2013) 0.85
Botulinum toxin for subacute/chronic neck pain. Cochrane Database Syst Rev (2011) 0.84
Intersubband gain-induced dispersion. Opt Lett (2009) 0.84
A qualitative and quantitative survey of Forensic Medical Examiner workload in the Northumbria Police Force area October 2002-January 2003. J Clin Forensic Med (2005) 0.83
The social determinants of child health. Soc Sci Med (2013) 0.82
Update on chronic hepatitis C. Clin Gastroenterol Hepatol (2005) 0.81
Hepatitis C virus: a critical appraisal of approaches to therapy. Clin Gastroenterol Hepatol (2008) 0.81
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity. Mol Cancer Ther (2004) 0.81
Conventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation: comparison of explant pathologic response. Transplantation (2014) 0.81
Evaluation of active bleeding into hematomas by technetium-99m red blood cell scintigraphy before angiography. Clin Nucl Med (2002) 0.81
Using Web 2.0 technologies to develop a resource for evidence based medicine. AMIA Annu Symp Proc (2006) 0.81
Small bowel angioedema associated with angiotensin converting enzyme inhibitor use. J Gen Intern Med (2010) 0.81
Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia. Clin Cancer Res (2002) 0.81
Entrapment of the StarClose Vascular Closure System after attempted common femoral artery deployment. Cardiovasc Intervent Radiol (2011) 0.81
Druggability assessment of protein-protein interfaces. Future Med Chem (2011) 0.81
Acute hepatitis C in an HIV-infected patient: a case report and review of literature. J Gen Intern Med (2012) 0.81
Endovascular closure of a portocaval shunt after left lobe liver transplantation using an Amplatzer muscular ventricular septal occluder device. Liver Transpl (2011) 0.80
Use of uptake intrinsic clearance from attached rat hepatocytes to predict hepatic clearance for poorly permeable compounds. Xenobiotica (2012) 0.80
Computer alerts for potassium testing: resisting the temptation of a blanket approach. J Am Med Inform Assoc (2004) 0.80
Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Clin Transplant (2013) 0.80
Adult-Onset Fatal Neurohepatopathy in a Woman Caused by MPV17 Mutation. JIMD Rep (2013) 0.80
Microchip-associated leiomyosarcoma in an Egyptian fruit bat (Rousettus aegyptiacus). J Zoo Wildl Med (2007) 0.80
Response to letter to the editors. Liver Transpl (2014) 0.80
Ratios of biliary glutathione disulfide (GSSG) to glutathione (GSH): a potential index to screen drug-induced hepatic oxidative stress in rats and mice. Anal Bioanal Chem (2013) 0.80
Transplant tourism and unregulated black-market trafficking of organs. Am J Transplant (2009) 0.80